Department of Pediatrics, Section of Critical Care Medicine, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.
Department of Vaccines and Immunity, Medical Research Council the Gambia Unit at the London School of Hygiene and Tropical Medicine, UK.
Vaccine. 2021 May 21;39(22):3028-3036. doi: 10.1016/j.vaccine.2021.01.053. Epub 2021 Jan 28.
This is a Brighton Collaboration Case Definition of the term "Acute Respiratory Distress Syndrome - ARDS" to be utilized in the evaluation of adverse events following immunization. The Case Definition was developed by a group of experts convened by the Coalition for Epidemic Preparedness Innovations (CEPI) in the context of active development of vaccines for SARS-CoV-2 vaccines and other emerging pathogens. The case definition format of the Brighton Collaboration was followed to develop a consensus definition and defined levels of certainty, after an exhaustive review of the literature and expert consultation. The document underwent peer review by the Brighton Collaboration Network and by selected Expert Reviewers prior to submission. The comments of the reviewers were taken into consideration and edits incorporated in this final manuscript.
这是 Brighton 协作组织对“急性呼吸窘迫综合征 - ARDS”一词的定义,用于评估疫苗接种后不良反应。该病例定义由流行病防范创新联盟 (CEPI) 召集的专家组在积极开发 SARS-CoV-2 疫苗和其他新出现病原体疫苗的背景下制定。在对文献进行详尽审查和专家咨询后,采用 Brighton 协作组织的病例定义格式制定了共识定义和确定性级别。该文件在提交前经过了 Brighton 协作组织网络和选定的专家审查员的同行评审。评审员的意见已被考虑在内,并在最终手稿中进行了编辑。